In partnership with The Michael J. Fox Foundation (MJFF), Sage Bionetworks today announced results from the Parkinson's Disease Digital Biomarker DREAM challenge, a research project designed to look for objective digital measures, or biomarkers, of Parkinson's disease (PD). There currently are no Parkinson's biomarkers.
The DREAM challenge asked experts to analyze data from two studies, including MJFF's Levodopa Response Trial. The project aimed to help researchers identify ways to use smartphones and wearable devices to diagnose and track PD. Winners developed methods to detect PD from a walk and balance test, and predict severity of different Parkinson's symptoms using wearables. These approaches could increase the ability to monitor PD outside of doctors' visits. Learn more about the winning projects and next steps.